Lessons From the Success and Failure of Targeted Drugs for Rheumatoid Arthritis: Perspectives for Effective Basic and Translational Research
Open Access
- 1 January 2022
- journal article
- review article
- Published by XMLink in Immune Network
- Vol. 22 (1) , e8
Abstract
Kim M, et al. Immune Netw. 2022 Feb;22(1):e8. https://doi.org/10.4110/in.2022.22.e8Keywords
Funding Information
- National Research Foundation of Korea (NRF-2020R1C1C1007944)
- Korea Health Industry Development Institute (HI14C1277)
This publication has 126 references indexed in Scilit:
- “Go upstream, young man”: lessons learned from the p38 sagaAnnals of the Rheumatic Diseases, 2010
- Blocking Interleukin‐1 in Rheumatic DiseasesAnnals of the New York Academy of Sciences, 2009
- The 6-month safety and efficacy of abatacept in patients with rheumatoid arthritis who underwent a washout after anti-tumour necrosis factor therapy or were directly switched to abatacept: the ARRIVE trialAnnals of the Rheumatic Diseases, 2009
- The Subendothelial Extracellular Matrix Modulates JNK Activation by FlowCirculation Research, 2009
- IL-17 and Th17 CellsAnnual Review of Immunology, 2009
- Low Intensity Shear Stress Increases Endothelial ELR+ CXC Chemokine Production via a Focal Adhesion Kinase-p38β MAPK-NF-κB PathwayJournal of Biological Chemistry, 2009
- Efficacy and safety of abatacept or infliximab vs placebo in ATTEST: a phase III, multi-centre, randomised, double-blind, placebo-controlled study in patients with rheumatoid arthritis and an inadequate response to methotrexateAnnals of the Rheumatic Diseases, 2008
- The kinase p38α serves cell type–specific inflammatory functions in skin injury and coordinates pro- and anti-inflammatory gene expressionNature Immunology, 2008
- p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseasesNature Reviews Drug Discovery, 2003
- Evolving concepts of rheumatoid arthritisNature, 2003